2025 second_quarter Filing

Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing.
H.R. 946/S.1862, ORPHAN Cures Act. Issues related to access to home infusion.
H.R.1, One Big Beautiful Bill Act, as it relates to drug pricing and pharmacy benefit management reforms. Issues related to Most Favored Nation drug pricing.

Issues related to the Orphan Drug Tax Credit.
H.R. 1, One Big Beautiful Bill Act, as it relates to corporate and international taxes.

Issues related to medication step therapy.
S.864, HELP Copays Act, as it relates to out-of-pocket costs for prescription drugs. Issues related to pharmacy benefit management reforms.

Issues related to tariffs.